178,675 research outputs found
Chapple, F R, VX25876
No full textThis record was harvested from a previous catalogue system and will be withdrawn in 2025. Information in this record may be superseded or incomplete. Visit this record in UMA's new catalogue at: https://archives.library.unimelb.edu.au/nodes/view/376756Surname: CHAPPLE
Given Name(s) or Initials: F R
Military Service Number or Last Known Location: VX25876
Missing, Wounded and Prisoner of War Enquiry Card Index Number: 38753190515
Item: [2016.0049.09061] "Chapple, F R, VX25876
Chapple, A R, VX45551
No full textThis record was harvested from a previous catalogue system and will be withdrawn in 2025. Information in this record may be superseded or incomplete. Visit this record in UMA's new catalogue at: https://archives.library.unimelb.edu.au/nodes/view/376758Surname: CHAPPLE
Given Name(s) or Initials: A R
Military Service Number or Last Known Location: VX45551
Missing, Wounded and Prisoner of War Enquiry Card Index Number: 43138190517
Item: [2016.0049.09063] "Chapple, A R, VX45551
Chapple, A R, VX30070
No full textThis record was harvested from a previous catalogue system and will be withdrawn in 2025. Information in this record may be superseded or incomplete. Visit this record in UMA's new catalogue at: https://archives.library.unimelb.edu.au/nodes/view/376757Surname: CHAPPLE
Given Name(s) or Initials: A R
Military Service Number or Last Known Location: VX30070
Missing, Wounded and Prisoner of War Enquiry Card Index Number: 6978190516
Item: [2016.0049.09062] "Chapple, A R, VX30070
Data from Chapple et al "Biological invasions as a selective filter driving behavioral divergence"
No full textData and R code for Chapple et al "Biological invasions as a selective filter driving behavioral divergence"
Individual patient data from registrational trials of silodosin in the treatment of non-neurogenic male lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH): Subgroup analyses of efficacy and safety data
No full textObjective To evaluate efficacy and safety of silodosin in a pooled analysis of individual patient data from three registrational randomised controlled trials (RCTs) comparing silodosin and placebo in patients with lower urinary tract symptoms (LUTS). Patients and Methods A pooled analysis of 1494 patients from three 12-week, multicentre, double-blind, placebo-controlled phase III RCTs was performed. Efficacy and safety data were assessed across patients with different baseline characteristics. Results Silodosin was significantly more effective than placebo in improving all International Prostate Symptom Score (IPSS)-related parameters, and maximum urinary flow rate (Qmax) regardless of patients age (P < 0.041). Comparing the efficacy of silodosin in the different age groups, there were no differences for all the IPSS-related parameters, whereas Qmax improvement was slightly higher in patients aged <65 years (P = 0.009). Silodosin was significantly more effective than placebo in reducing all IPSS-related parameters regardless of baseline IPSS (P ≤ 0.001). Similarly, silodosin was more effective than placebo in improving IPSS-related parameters regardless of baseline Qmax (P ≤ 0.02). Silodosin was associated with significantly higher adverse event (AE) rates, compared with placebo, in all patient subgroups, with retrograde ejaculation being the most common. Prevalence of dizziness, orthostatic hypotension, and discontinuation rate was similar with silodosin and placebo in most patient subgroups. Conclusions We analysed the efficacy and safety of silodosin in several patient subgroups, showing that silodosin was more effective than placebo in improving all IPSS-related parameters in all patient subgroups, whereas AEs were similar. Notably, cardiovascular AEs were not higher in patients taking antihypertensive drugs or with mild renal function impairment. Discontinuation rates due to AEs were lower in elderly patients
A pooled analysis of individual patient data from registrational trials of silodosin in the treatment of non-neurogenic male lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH)
No full textTo evaluate the efficacy and safety of silodosin in a pooled analysis based on individual patients data from three randomised controlled trials (RCTs) comparing silodosin and placebo
Oligosoma roimata Patterson, Hitchmough & Chapple, 2013, sp. nov.
No full textOligosoma roimata sp. nov. Figure 3 Sphenomorphus pseudornatus: McCann 1955 (in part): 76-7, 110 - 11, 125. Cyclodina ornata: Hardy 1977 (in part): 261 - 64. Cyclodina sp. 3: Jewell 2008: 112. Oligosoma ornatum: Chapple et al. 2009 (in part): 472, 485. Holotype. Aorangi Island, Poor Knights (35 º 28 ’S, 174 º 44 ’E), NMNZ RE001626# 32 (adult male) (coll. G.S. Hardy, November 1973). (Figure 3). Paratypes (4 specimens). Aorangi Island, Poor Knights (35 º 28 ’S, 174 º 44 ’E), NMNZ RE003723 (S 78) (male) (coll. Coll. A.H. Whitaker, December 1964); Aorangi Island, Poor Knights (35 º 28 ’S, 174 º 44 ’E), NMNZ RE001626# 29 (female), NMNZ RE001626# 30 (male), NMNZ RE001626# 31 (male) (coll. G.S. Hardy, November 1973). Diagnosis. Oligosoma roimata sp. nov. can be distinguished from other Oligosoma species through a combination of characters. The clearly visible orange iris separates the species from all other Oligosoma except O. aeneum, O. levidensum, O. hardyi, O. townsi, O. oliveri, O. macgregori, O. whitakeri, O. striatum, O. homalonotum, and O. ornatum. The unbroken subocular scale row separates O. roimata sp. nov. from O. striatum, O. homalonotum.and O. hardyi. Oligosoma roimata sp. nov. has a prominent teardrop marking under the eye, and a moderately large ear opening, which separates it from O. aeneum, O. levidensum and O. hardyi which lack this marking and have small ear openings. Oligosoma townsi midbody scale count of ≥ 38 does not overlap with O. roimata sp. nov.. The maximum SVL of 62 mm (Whitaker 1968) is much less than that of O. oliveri (105.6 mm), the ear opening is smaller than in O. oliveri and most O. oliveri specimens have two primary temporals (Chapple et al. 2008 a), whereas O. roimata sp. nov. always has one. There is minimal overlap between O. roimata sp. nov. and O. whitakeri in midbody and no overlap in ventral scale counts with O. whitakeri having a higher range for both indices (Hardy 1977). Oligosoma roimata sp. nov. lacks the yellow and orange colouration of many O. whitakeri specimens (Hardy 1977). Oligosoma whitakeri generally has dark blotches on the ventral surface, whereas it is unmarked or lightly marked in O. roimata sp. nov.. Colour pattern distinguishes O. roimata sp. nov. from O. macgregori and there is no overlap in midbody or ventral scale counts between these two species. The ear opening is slightly smaller than in O. ornatum and the maximum SVL is much less than O. ornatum (84.0 mm). Description of Holotype. Body elongate, squarish in cross-section; limbs moderately well-developed, pentadactyl. Lower eyelid with a large, sometimes divided opaque central scale, bordered anteriorly and posteriorly by relatively large scales. Snout moderately blunt. Nostril centred just below middle of nasal, not touching bottom edge of nasal. Supranasals absent. Rostral broader than deep. Frontonasal broader than long, not separated from frontal by prefrontals meeting in midline. Frontal longer than broad, shorter than frontoparietal and interparietal together, in contact with 2 anteriormost supraoculars. Supraoculars 4, the second largest. Preoculars 2, the upper one larger. Frontoparietals distinct, larger than interparietal. A pair of parietals meeting behind interparietal and bordered posteriorly by a pair each of nuchals and temporals, also in contact with interparietal, frontoparietal, fourth supraocular and 2 postoculars. Loreals 2, similar size; anterior loreal in contact with first and second supralabial, posterior loreal, prefrontal, frontonasal and nasal; posterior loreal in contact with second and third supralabial, first subocular, upper and lower preocular, prefrontal and anterior loreal. Supralabials 7, the sixth largest. Infralabials 6, several of them equal in size; fifth supralabial below centre of eye. Mental broader but shallower than rostral. Suboculars series continuous. Postmental larger than mental. Chinshields 3 pairs. One primary temporal. Dorsal scales largest, weakly striate. Ventral scales smooth. Subdigital lamellae smooth. Ear opening round, moderately large, with no projecting granules. Forelimbs shorter than hindlimbs. Adpressed limbs almost meeting in adult. Digits short, sub-cylindrical. Third front digit shorter than the fourth. Measurements (in Millimeters; Holotype with the Variation Shown in the Type Series in Parentheses): SVL 57.0 (mean 57.0, range 48.5–63.6), HL 8.3 (mean 8.7, range 8.1–9.2), HW 6.1 (mean 6.1, range 6.4–6.5), AG 31.0 (mean 28.3, range 21.7–33.2), SF 23.9 (mean 23.0, range 21–24.8), S-E 11.7 (mean 11.3, range 9.6–12), EF 12.9 (mean 12.1, range 10.5–13.5), and TL incomplete (no specimens with intact tails). Scalation (Holotype with the Variation Shown in the Type Series in Parentheses): Upper ciliaries 7 (mean 6, range 6-7); lower ciliaries 11 (mean 10, range 10–11); nuchals 1 pair (mean 1 pair, range 1 - 1 pairs); midbody scale rows 34 (mean 33, range 32–34); ventral scale rows 68 (mean 69, range 65–72); subdigital lamellae 24 (mean 22, range 21–24); supraciliaries 7 (mean 7, range 7 - 7); suboculars 9 (mean 9, range 8–9). Frontonasal never separated from frontal by prefrontals meeting in midline. Anterior loreal in contact with first and second supralabial. Posterior loreal in contact with second and third supralabial. Supralabials 7, the sixth largest. Infralabials 6. One primary temporal. Third front digit usually shorter than the fourth. Maximum SVL 63.6 mm. Ratios for morphological measurements (± SD): AG/SF 1.23 ± 0.14; SE/EF 0.94 ± 0.05; HL/HW 1.41 ± 0.05. Colouration. Dorsal surface light brown to very dark brown, with irregular dark and light flecks or blotches, shading into white ventral surface (Figure 4). A white, black-edged “tear-drop” under eye, although this may be indistinct in some animals. Well marked pale dorsolateral stripe from near tip of snout to near midpoint of body, thereafter broken up by brown patches. Throat, chin and belly lightly speckled. There do not appear to be sexually dimorphic colour patterns. Juvenile colouration is unknown. Etymology. From the Maori “ roimata ” = “tears”, referring to the teardrop marking under the eyes. The suggested common name is the Aorangi skink. Habitat and life history. Oligosoma roimata sp. nov. is known only from the Poor Knights Islands, which are an island chain just over 20 km NE of the northern North Island. They consist of two large islands (larger than 1 km 2) and several smaller islands and rock stacks. In total, the group is approximately 2.8 km 2 in area. The Poor Knights Islands are administered by the Department of Conservation as a Nature Reserve. The islands are unique in that they have never been invaded by introduced mammalian predators. The exception is Aorangi Island, onto which Maori introduced feral pigs from stock obtained from European ships toward the end of the eighteenth century. The pigs were extirpated in 1936. Consequently, the Poor Knights Islands support a diverse range of reptile species, which can attain extremely high densities compared to mainland populations. The islands are now known to have three endemic lizard species; Oligosoma roimata sp. nov., the Poor Knights gecko (Dactylocnemis sp.) and Hardy’s skink (O. hardyi). They also support populations of marbled skink (O. oliveri) which have a highly distinctive morphology, egg-laying skink (O. suteri (Boulenger, 1906)), moko skink (O. moco (Dumeril & Bibron, 1839)), shore skink (O. smithi (Gray, 1845)) and Duvaucel’s gecko (Hoplodactylus duvaucelii (Dumeril & Bibron, 1836)). Oligosoma roimata sp. nov. is most abundant in flax and scrub on the fringes of the islands. It appears to favour dense ground cover. It is most active at dawn and dusk and appears to be mainly insectivorous (Whitaker 1968). The species is currently listed in the New Zealand Threat Classification System as Naturally Uncommon (Hitchmough et al. 2013); however, since population densities appear to be sparse and several recent surveys have failed to detect any animals (Trent Bell, pers. comm.; R. Parrish, pers. comm.), the species may warrant an enhanced conservation status.Published as part of Patterson, Geoff B., Hitchmough, Rod A. & Chapple, David G., 2013, Taxonomic revision of the ornate skink (Oligosoma ornatum; Reptilia: Scincidae) species complex from northern New Zealand in Zootaxa 3736 (1), DOI: 10.11646/zootaxa.3736.1.2, http://zenodo.org/record/22243
Editorial
No full textWelcome to the 30th volume of the Accounting Research Journal, signifying 30 years of scholarly publishing.
I intend to dedicate this editorial to recognise the work of a variety of participants in contributing to the Journal’s success, including a tribute to our colleague and past author, Dr Acklesh Prasad, who passed away unexpectedly in June 2016.No Full Tex
Appropriate Similarity Measures for Author Cocitation Analysis
No full textWe provide a number of new insights into the methodological discussion about author cocitation analysis. We first argue that the use of the Pearson correlation for measuring the similarity between authors’ cocitation profiles is not very satisfactory. We then discuss what kind of similarity measures may be used as an alternative to the Pearson correlation. We consider three similarity measures in particular. One is the well-known cosine. The other two similarity measures have not been used before in the bibliometric literature. Finally, we show by means of an example that our findings have a high practical relevance.information science;Pearson correlation;cosine;similarity measure;author cocitation analysis
Who will win the electric vehicle race? The role of place-based assets and policy
No full textRegional economies are shaped by their economic histories and existing endowments. This paper explores the question: how do a region’s economic history and institutional endowments affect its success and trajectory in an emerging industry? Our case, electric vehicle development and production, is an industry which combines more traditional skilled manufacturing with knowledge-driven innovation activities. We present deep qualitative case studies of two regions, focusing on one firm in each. The case of Tesla in the San Francisco Bay Area examines an electric vehicle firm in a region with a strong tech innovation system, while the case of Maserati in Emilia-Romagna, Italy, examines a firm that builds on a regional history of automotive manufacturing. Across cases, we compare regional skill endowments, institutional coordination, and place-based policymaking. We conclude that, as an emerging industry under a new economic paradigm, electric vehicle manufacturing by Tesla and Maserati represents two different conceptions of
the industry and consequently two different location strategies. Yet these two strategies remain rooted in regional contexts, owing both their success to successful exploitations of these, and their struggles to their failure to compensate for regional gaps. This presents a clear opportunity for place-based industrial strategy to evolve and intervene
- …
